Skip to main content
Erschienen in: Current Treatment Options in Neurology 5/2013

01.10.2013 | PEDIATRIC NEUROLOGY (HS SINGER, SECTION EDITOR)

Sturge-Weber Syndrome

verfasst von: Catherine D. Bachur, BA, Anne M. Comi, MD

Erschienen in: Current Treatment Options in Neurology | Ausgabe 5/2013

Einloggen, um Zugang zu erhalten

Opinion statement

We try to see the babies prior to the onset of symptoms so that their parents can receive anticipatory guidance regarding seizures and how to recognize and respond to them and so that proper referrals to ophthalmology can be made. If there is any concern on history, exam, or EEG then we obtain a magnetic resonance imaging (MRI) with contrast. If presymptomatic diagnosis of brain involvement is made then treatment with low-dose aspirin is offered and if the brain involvement is extensively bilateral then an anticonvulsant such as levetiracetam is offered as well. Seizures are treated aggressively with a goal of obtaining and maintaining complete seizure suppression as much as possible often with a combination of low-dose aspirin and two anticonvulsants such as levetiracetam and oxcarbazepine. For many patients, this will provide adequate control of their seizures and stroke-like episodes. If the patient fails medical management and seizures are regular and accompanied by plateaued development, significant hemiparesis and visual field deficit and the patient is unilaterally involved and a surgical candidate then surgical management is urged. When the seizures are less regular, little or no hemiparesis or visual field deficit exist, and development is reasonable then this decision is more difficult. For bilaterally involved patients surgery is usually not a good option unless seizures are very severe and mostly coming from one side. Other therapeutic options include the ketogenic/Atkins diet and vagal nerve stimulator although in our experience these usually do not result in cessation of seizures. Endocrine problems occur with increased frequency and must be treated when they are present. The recent discovery of the somatic mutation causing Sturge-Weber syndrome holds promise for new treatment options in the future.
Literatur
1.
Zurück zum Zitat Enjolras O, Riche MC, Merland JJ. Facial port-wine stains and Sturge-Weber syndrome. Pediatrics. 1985;76:48–51.PubMed Enjolras O, Riche MC, Merland JJ. Facial port-wine stains and Sturge-Weber syndrome. Pediatrics. 1985;76:48–51.PubMed
2.
Zurück zum Zitat Tallman B, Tan OT, Morelli JG, et al. Location of port-wine stains and the likelihood of ophthalmic and/or central nervous system complications. Pediatrics. 1991;87:323–7.PubMed Tallman B, Tan OT, Morelli JG, et al. Location of port-wine stains and the likelihood of ophthalmic and/or central nervous system complications. Pediatrics. 1991;87:323–7.PubMed
3.
Zurück zum Zitat Melancon JM, Dohil MA, Eichenfield LF. Facial port-wine stain: when to worry? Pediatr Dermatol. 2012;29(1):131–3.PubMedCrossRef Melancon JM, Dohil MA, Eichenfield LF. Facial port-wine stain: when to worry? Pediatr Dermatol. 2012;29(1):131–3.PubMedCrossRef
4.
Zurück zum Zitat Piram M, Lorette G, Sirinelli D, et al. Sturge-Weber syndrome in patients with facial port-wine stain. Pediatr Dermatol. 2012;29(1):32–7.PubMedCrossRef Piram M, Lorette G, Sirinelli D, et al. Sturge-Weber syndrome in patients with facial port-wine stain. Pediatr Dermatol. 2012;29(1):32–7.PubMedCrossRef
5.•
Zurück zum Zitat Nabbout R, Juhasz C. Sturge-Weber syndrome. Handb Clin Neurol. 2013;111:315–21. This article addresses the most updated techniques for MRI imagining in Sturge-Weber syndrome. It is important to understand these methods in order to accurately diagnose brain involvement and to prescribe treatment options accordingly.PubMedCrossRef Nabbout R, Juhasz C. Sturge-Weber syndrome. Handb Clin Neurol. 2013;111:315–21. This article addresses the most updated techniques for MRI imagining in Sturge-Weber syndrome. It is important to understand these methods in order to accurately diagnose brain involvement and to prescribe treatment options accordingly.PubMedCrossRef
6.
Zurück zum Zitat Ewen JB, Kossoff EH, Crone NE, et al. Use of quantitative EEG in infants with port-wine birthmark to assess for Sturge-Weber brain involvement. Clin Neurophysiol. 2009;120(8):1433–40.PubMedCrossRef Ewen JB, Kossoff EH, Crone NE, et al. Use of quantitative EEG in infants with port-wine birthmark to assess for Sturge-Weber brain involvement. Clin Neurophysiol. 2009;120(8):1433–40.PubMedCrossRef
7.
Zurück zum Zitat Hatfield LA, Crone NE, Kossoff EH, et al. Quantitative EEG asymmetry correlates with clinical severity in unilateral Sturge-Weber syndrome. Epilepsia. 2007;48(1):191–5.PubMedCrossRef Hatfield LA, Crone NE, Kossoff EH, et al. Quantitative EEG asymmetry correlates with clinical severity in unilateral Sturge-Weber syndrome. Epilepsia. 2007;48(1):191–5.PubMedCrossRef
8.••
Zurück zum Zitat Shirley MD, Tang H, Gallione CJ, et al. Sturge-Weber syndrome and port-wine stains caused by somatic mutation in GNAQ. N Engl J Med. 2013;368(21):1971–9. This article uncovers the somatic mosaic genetic basis for port wine birthmarks and Sturge-Weber syndrome. The article also utilizes transient transfections to determine the impact of the GNAQ mutation upon downstream phosphorylated proteins.PubMedCrossRef Shirley MD, Tang H, Gallione CJ, et al. Sturge-Weber syndrome and port-wine stains caused by somatic mutation in GNAQ. N Engl J Med. 2013;368(21):1971–9. This article uncovers the somatic mosaic genetic basis for port wine birthmarks and Sturge-Weber syndrome. The article also utilizes transient transfections to determine the impact of the GNAQ mutation upon downstream phosphorylated proteins.PubMedCrossRef
9.
Zurück zum Zitat Comi AC. Presentation, diagnosis, pathophysiology, and treatment of the neurological features of Sturge-Weber syndrome. Neurologist. 2011;17(4):179–84.PubMedCrossRef Comi AC. Presentation, diagnosis, pathophysiology, and treatment of the neurological features of Sturge-Weber syndrome. Neurologist. 2011;17(4):179–84.PubMedCrossRef
10.
Zurück zum Zitat Traub R, Riley C, Horvath S. Teaching NeuroImages: Sturge-Weber syndrome presenting in a 58-year old woman with seizures. Neurology. 2010;75(12):e52.PubMedCrossRef Traub R, Riley C, Horvath S. Teaching NeuroImages: Sturge-Weber syndrome presenting in a 58-year old woman with seizures. Neurology. 2010;75(12):e52.PubMedCrossRef
11.
Zurück zum Zitat Kumar KR, Hon K, Schultz D, et al. Transient changes on brain magnetic resonance imaging in a patient with Sturge-Weber syndrome presenting with hemiparesis. Neurologist. 2009;15(6):351–4.PubMedCrossRef Kumar KR, Hon K, Schultz D, et al. Transient changes on brain magnetic resonance imaging in a patient with Sturge-Weber syndrome presenting with hemiparesis. Neurologist. 2009;15(6):351–4.PubMedCrossRef
12.
Zurück zum Zitat Zolkipli Z, Aylett S, Rankin PM, et al. Transient exacerbation of hemiplegia following minor head trauma in Sturge-Weber syndrome. Dev Med Child Neurol. 2007;49:697–9.PubMedCrossRef Zolkipli Z, Aylett S, Rankin PM, et al. Transient exacerbation of hemiplegia following minor head trauma in Sturge-Weber syndrome. Dev Med Child Neurol. 2007;49:697–9.PubMedCrossRef
13.
Zurück zum Zitat Bebin EM, Gomez MR. Prognosis in Sturge-Weber disease: comparison of unihemispheric and bihemispheric involvement. J Child Neurol. 1988;3:181–4.PubMedCrossRef Bebin EM, Gomez MR. Prognosis in Sturge-Weber disease: comparison of unihemispheric and bihemispheric involvement. J Child Neurol. 1988;3:181–4.PubMedCrossRef
14.
Zurück zum Zitat Oakes WJ. The natural history of patients with the Sturge-Weber syndrome. Pediatr Neurosurg. 1992;18:287–90.PubMedCrossRef Oakes WJ. The natural history of patients with the Sturge-Weber syndrome. Pediatr Neurosurg. 1992;18:287–90.PubMedCrossRef
15.••
Zurück zum Zitat Raches D, Hiscock M, Chapieski L. Behavioral and academic problems in children with Sturge-Weber syndrome: differences between children with and without seizures. Epilepsy Behav. 2012;25(3):457–63. This article addresses the neurological cognitive impairments that can accompany Sturge-Weber syndrome. As cognitive impairments are thought to be a direct result of seizure activity, successful treatment is necessary to prevent them.PubMedCrossRef Raches D, Hiscock M, Chapieski L. Behavioral and academic problems in children with Sturge-Weber syndrome: differences between children with and without seizures. Epilepsy Behav. 2012;25(3):457–63. This article addresses the neurological cognitive impairments that can accompany Sturge-Weber syndrome. As cognitive impairments are thought to be a direct result of seizure activity, successful treatment is necessary to prevent them.PubMedCrossRef
16.
Zurück zum Zitat Namer IJ, Battaglia F, Hirsch E, et al. Subtraction ictal SPECT co-registered to MRI (SISCOM) in Sturge-Weber syndrome. Clin Nucl Med. 2005;30:39–40.PubMedCrossRef Namer IJ, Battaglia F, Hirsch E, et al. Subtraction ictal SPECT co-registered to MRI (SISCOM) in Sturge-Weber syndrome. Clin Nucl Med. 2005;30:39–40.PubMedCrossRef
17.
Zurück zum Zitat Aylett SE, Neville BG, Cross JH, et al. Sturge-Weber syndrome: cerebral hemodynamics during seizure activity. Dev Med Child Neurol. 1999;41:480–5.PubMedCrossRef Aylett SE, Neville BG, Cross JH, et al. Sturge-Weber syndrome: cerebral hemodynamics during seizure activity. Dev Med Child Neurol. 1999;41:480–5.PubMedCrossRef
18.
Zurück zum Zitat Juhasz C, Lai C, Behen ME, et al. White matter volume as a major predictor of cognitive function in Sturge-Weber syndrome. Arch Neurol. 2007;64(8):1169–74.PubMedCrossRef Juhasz C, Lai C, Behen ME, et al. White matter volume as a major predictor of cognitive function in Sturge-Weber syndrome. Arch Neurol. 2007;64(8):1169–74.PubMedCrossRef
19.
Zurück zum Zitat Kossoff EH, Hatfield LA, Ball KL, et al. Comorbidity of epilepsy and headache in patients with Sturge-Weber syndrome. J Child Neurol. 2005;20(8):678–82.PubMedCrossRef Kossoff EH, Hatfield LA, Ball KL, et al. Comorbidity of epilepsy and headache in patients with Sturge-Weber syndrome. J Child Neurol. 2005;20(8):678–82.PubMedCrossRef
20.
Zurück zum Zitat Vainionpaa LK, Mikkonen K, Rattya J, et al. Thyroid function in girls with epilepsy with carbamazepine, oxcarbazepine, and valproate. Pediatr Int. 2004;45:197–203. Vainionpaa LK, Mikkonen K, Rattya J, et al. Thyroid function in girls with epilepsy with carbamazepine, oxcarbazepine, and valproate. Pediatr Int. 2004;45:197–203.
21.••
Zurück zum Zitat Lance EI, Sreenivasan AK, Zabel TA, et al. Aspirin use in Sturge-Weber syndrome: side effects and clinical outcomes. J Child Neurol. 2012;28(2):213–8. This article offers direct evidence for the safety of aspirin use among Sturge-Weber syndrome patients and suggests that aspirin is a practical and useful treatment for these patients.PubMedCrossRef Lance EI, Sreenivasan AK, Zabel TA, et al. Aspirin use in Sturge-Weber syndrome: side effects and clinical outcomes. J Child Neurol. 2012;28(2):213–8. This article offers direct evidence for the safety of aspirin use among Sturge-Weber syndrome patients and suggests that aspirin is a practical and useful treatment for these patients.PubMedCrossRef
22.
Zurück zum Zitat Ville D, Enjolras O, Chiron C, et al. Prophylactic antiepileptic treatment in Sturge-Weber disease. Seizure. 2002;11(3):145–50.PubMedCrossRef Ville D, Enjolras O, Chiron C, et al. Prophylactic antiepileptic treatment in Sturge-Weber disease. Seizure. 2002;11(3):145–50.PubMedCrossRef
23.
Zurück zum Zitat Arzimanoglou A, Aicardi J. The epilepsy of Sturge-Weber syndrome: clinical features and treatment in 23 patients. Acta Neurol Scand Suppl. 1992;140:18–22.PubMedCrossRef Arzimanoglou A, Aicardi J. The epilepsy of Sturge-Weber syndrome: clinical features and treatment in 23 patients. Acta Neurol Scand Suppl. 1992;140:18–22.PubMedCrossRef
24.
Zurück zum Zitat Sujansky E, Conradi S. Sturge-Weber syndrome: age of onset of seizures and glaucoma and the prognosis for affected children. J Child Neurol. 1995;10:49–58.PubMedCrossRef Sujansky E, Conradi S. Sturge-Weber syndrome: age of onset of seizures and glaucoma and the prognosis for affected children. J Child Neurol. 1995;10:49–58.PubMedCrossRef
25.
Zurück zum Zitat Kossoff EH, Borsage JL, Comi AM. A pilot study of the modified Atkins diet for Sturge-Weber Syndrome. Epilepsy Res. 2010;92(2–3):240–3.PubMedCrossRef Kossoff EH, Borsage JL, Comi AM. A pilot study of the modified Atkins diet for Sturge-Weber Syndrome. Epilepsy Res. 2010;92(2–3):240–3.PubMedCrossRef
26.
Zurück zum Zitat Schramm J, Kuczaty S, Sassen R, et al. Pediatric functional hemipherectomy: outcome in 92 patients. Acta Neurochir. 2012;154(11):2017–28.PubMedCrossRef Schramm J, Kuczaty S, Sassen R, et al. Pediatric functional hemipherectomy: outcome in 92 patients. Acta Neurochir. 2012;154(11):2017–28.PubMedCrossRef
27.
Zurück zum Zitat Kossoff EH, Buck C, Freeman JM. Outcomes of 32 hemispherectomies for Sturge-Weber syndrome worldwide. Neurology. 2002;59(11):1735–8.PubMedCrossRef Kossoff EH, Buck C, Freeman JM. Outcomes of 32 hemispherectomies for Sturge-Weber syndrome worldwide. Neurology. 2002;59(11):1735–8.PubMedCrossRef
28.
Zurück zum Zitat Bourgeois M, Crimmins DW, de Oliveira RS, et al. Surgical treatment of epilepsy in Sturge-Weber syndrome in children. J Neurosurg. 2007;106(1 Suppl):20–8.PubMed Bourgeois M, Crimmins DW, de Oliveira RS, et al. Surgical treatment of epilepsy in Sturge-Weber syndrome in children. J Neurosurg. 2007;106(1 Suppl):20–8.PubMed
29.
Zurück zum Zitat Arzimanoglou AA, Andermann F, Aicardi J, et al. Sturge-Weber syndrome: indications and results of surgery in 20 patients. Neurology. 2000;55:1472–9.PubMedCrossRef Arzimanoglou AA, Andermann F, Aicardi J, et al. Sturge-Weber syndrome: indications and results of surgery in 20 patients. Neurology. 2000;55:1472–9.PubMedCrossRef
30.
Zurück zum Zitat Tuxhorn IE, Pannek HW. Epilepsy surgery in bilateral Sturge-Weber syndrome. Pediatr Neurol. 2002;26(5):394–7.PubMedCrossRef Tuxhorn IE, Pannek HW. Epilepsy surgery in bilateral Sturge-Weber syndrome. Pediatr Neurol. 2002;26(5):394–7.PubMedCrossRef
31.
Zurück zum Zitat Wiebe S, Berg AT. Big epilepsy surgery for little people: what’s the full story on hemispherectomy? Neurology. 2013;80(3):232–3.PubMedCrossRef Wiebe S, Berg AT. Big epilepsy surgery for little people: what’s the full story on hemispherectomy? Neurology. 2013;80(3):232–3.PubMedCrossRef
32.
Zurück zum Zitat Lo W, Marchuck DA, Ball KL, et al. Updates and future horizons on the understanding, diagnosis, and treatment of Sturge-Weber syndrome brain involvement. Dev Med Child Neurol. 2012;54:214–23.PubMedCrossRef Lo W, Marchuck DA, Ball KL, et al. Updates and future horizons on the understanding, diagnosis, and treatment of Sturge-Weber syndrome brain involvement. Dev Med Child Neurol. 2012;54:214–23.PubMedCrossRef
33.
Zurück zum Zitat Maria BL, Neufeld JA, Rosainz LC, et al. Central nervous system structure and function in Sturge-Weber syndrome: evidence of neurologic and radiologic progression. J Child Neurol. 1998;13(12):606–18.PubMedCrossRef Maria BL, Neufeld JA, Rosainz LC, et al. Central nervous system structure and function in Sturge-Weber syndrome: evidence of neurologic and radiologic progression. J Child Neurol. 1998;13(12):606–18.PubMedCrossRef
34.
Zurück zum Zitat Udani V, Pujar S, Munot P, et al. Natural history and magnetic resonance imaging follow-up in nine Sturge-Weber syndrome patients and clinical correlation. J Child Neurol. 2007;22(4):479–83.PubMedCrossRef Udani V, Pujar S, Munot P, et al. Natural history and magnetic resonance imaging follow-up in nine Sturge-Weber syndrome patients and clinical correlation. J Child Neurol. 2007;22(4):479–83.PubMedCrossRef
35.
Zurück zum Zitat Iizuka T, Sakai F, Yamakawa K, et al. Vasogenic leakage and the mechanism of migraine with prolonged aura in Sturge-Weber syndrome. Cephalalgia. 2004;24:767–70.PubMedCrossRef Iizuka T, Sakai F, Yamakawa K, et al. Vasogenic leakage and the mechanism of migraine with prolonged aura in Sturge-Weber syndrome. Cephalalgia. 2004;24:767–70.PubMedCrossRef
36.
Zurück zum Zitat Kossoff EH, Balasta M, Hatfield LM, et al. Self-reported treatment patterns in patients with Sturge-Weber syndrome and migraines. J Child Neurol. 2007;22:720–6.PubMedCrossRef Kossoff EH, Balasta M, Hatfield LM, et al. Self-reported treatment patterns in patients with Sturge-Weber syndrome and migraines. J Child Neurol. 2007;22:720–6.PubMedCrossRef
37.
38.
Zurück zum Zitat Ong T, Chia A, Nischal KK. Latanoprost in port-wine stain related pediatric glaucoma. Br J Ophthalmol. 2003;87:1091–3.PubMedCrossRef Ong T, Chia A, Nischal KK. Latanoprost in port-wine stain related pediatric glaucoma. Br J Ophthalmol. 2003;87:1091–3.PubMedCrossRef
39.
Zurück zum Zitat Yang CB, Freedman SF, Myers JS, et al. Use of latanoprost in the treatment of glaucoma associated with Sturge-Weber syndrome. Am J Ophthalmol. 1998;126:600–2.PubMedCrossRef Yang CB, Freedman SF, Myers JS, et al. Use of latanoprost in the treatment of glaucoma associated with Sturge-Weber syndrome. Am J Ophthalmol. 1998;126:600–2.PubMedCrossRef
40.
Zurück zum Zitat Patrianakos TD, Nagao K, Walton DS. Surgical management of glaucoma with the Sturge-Weber syndrome. Int Ophthalmol Clin. 2008;48:63–78.PubMedCrossRef Patrianakos TD, Nagao K, Walton DS. Surgical management of glaucoma with the Sturge-Weber syndrome. Int Ophthalmol Clin. 2008;48:63–78.PubMedCrossRef
41.
Zurück zum Zitat Audren F, Abitbol O, Dureau P, et al. Nonpenetrating deep sclerectomy for glaucoma associated with Sturge-Weber syndrome. Acta Ophthalmol Scand. 2006;84:656–60.PubMedCrossRef Audren F, Abitbol O, Dureau P, et al. Nonpenetrating deep sclerectomy for glaucoma associated with Sturge-Weber syndrome. Acta Ophthalmol Scand. 2006;84:656–60.PubMedCrossRef
42.
Zurück zum Zitat Saltzmann RM, Reinecke S, Lin X, et al. Long-term outcomes of a pseudo 360-degree trabeculotomy ab externo technique for congenital glaucoma at children’s medical center. Clin Ophthalmol. 2012;6:289–98. Saltzmann RM, Reinecke S, Lin X, et al. Long-term outcomes of a pseudo 360-degree trabeculotomy ab externo technique for congenital glaucoma at children’s medical center. Clin Ophthalmol. 2012;6:289–98.
43.
Zurück zum Zitat Eivazi B, Roessler M, Pfützner W, et al. Port-wine stains are more than skin deep! Expanding the spectrum of extracutaneous manifestations of nevi flammei of the head and neck. Eur J Dermatol. 2012;22(2):246–51.PubMed Eivazi B, Roessler M, Pfützner W, et al. Port-wine stains are more than skin deep! Expanding the spectrum of extracutaneous manifestations of nevi flammei of the head and neck. Eur J Dermatol. 2012;22(2):246–51.PubMed
44.
Zurück zum Zitat Garzon MC, Huang JT, Enjolras O, et al. Vascular malformations: Part I. J Am Acad Dermatol. 2007;56(3):371–4.CrossRef Garzon MC, Huang JT, Enjolras O, et al. Vascular malformations: Part I. J Am Acad Dermatol. 2007;56(3):371–4.CrossRef
45.
Zurück zum Zitat Orten SS, Waner M, Flock S, et al. Port-wine stains. An assessment of 5 years of treatment. Arch Otolaryngol Head Neck Surg. 1996;122:1174–9.PubMedCrossRef Orten SS, Waner M, Flock S, et al. Port-wine stains. An assessment of 5 years of treatment. Arch Otolaryngol Head Neck Surg. 1996;122:1174–9.PubMedCrossRef
46.
Zurück zum Zitat Lam SM, Williams III EF. Practical considerations in the treatment of capillary vascular malformations, or port wine stains. Facial Plast Surg. 2004;20(1):71–6.PubMedCrossRef Lam SM, Williams III EF. Practical considerations in the treatment of capillary vascular malformations, or port wine stains. Facial Plast Surg. 2004;20(1):71–6.PubMedCrossRef
47.
Zurück zum Zitat Kane KS, Smoller BR, Fitzpatrick RE, et al. Pulsed-dye resistant port-wine stains. Arch Dermatol. 1996;132:839–41.PubMedCrossRef Kane KS, Smoller BR, Fitzpatrick RE, et al. Pulsed-dye resistant port-wine stains. Arch Dermatol. 1996;132:839–41.PubMedCrossRef
48.•
Zurück zum Zitat Tan W, Jia W, Sun V, et al. Topical rapamycin suppresses the angiogenesis pathways induced by pulsed dye laser: molecular mechanisms of inhibition of regeneration and revascularization of photocoagulated cutaneous blood vessels. Lasers Surg Med. 2012;44(10):796–804. This article advances a new approach in the treatment of port-wine birthmark which combines laser treatments with anti-angiogenesis treatment to prevent the regeneration of blood vessels obliterated by the laser treatment.PubMedCrossRef Tan W, Jia W, Sun V, et al. Topical rapamycin suppresses the angiogenesis pathways induced by pulsed dye laser: molecular mechanisms of inhibition of regeneration and revascularization of photocoagulated cutaneous blood vessels. Lasers Surg Med. 2012;44(10):796–804. This article advances a new approach in the treatment of port-wine birthmark which combines laser treatments with anti-angiogenesis treatment to prevent the regeneration of blood vessels obliterated by the laser treatment.PubMedCrossRef
49.
Zurück zum Zitat Miller RS, Ball KL, Comi AM, et al. Growth hormone deficiency in Sturge-Weber syndrome. Arch Dis Child. 2006;91(4):340–1.PubMedCrossRef Miller RS, Ball KL, Comi AM, et al. Growth hormone deficiency in Sturge-Weber syndrome. Arch Dis Child. 2006;91(4):340–1.PubMedCrossRef
50.
Zurück zum Zitat Comi AM, Bellamkonda S, Ferenc LM, et al. Central hypothyroidism and Sturge-Weber syndrome. Pediatr Neurol. 2008;39(1):58–62.PubMedCrossRef Comi AM, Bellamkonda S, Ferenc LM, et al. Central hypothyroidism and Sturge-Weber syndrome. Pediatr Neurol. 2008;39(1):58–62.PubMedCrossRef
51.
Zurück zum Zitat Saddique L, Sreenivasan A, Comi AM, et al. Important of utilizing a sensitive free thyroxine assay in Sturge-Weber syndrome. J Child Neurol. 2013;28(2):269–74.CrossRef Saddique L, Sreenivasan A, Comi AM, et al. Important of utilizing a sensitive free thyroxine assay in Sturge-Weber syndrome. J Child Neurol. 2013;28(2):269–74.CrossRef
52.
Zurück zum Zitat Reesman J, Gray R, Suskauer SJ, et al. Hemiparesis is a clinical correlate of general adaptive dysfunction in children and adolescents with Sturge-Weber syndrome. J Child Neurol. 2009;24:701–8.PubMedCrossRef Reesman J, Gray R, Suskauer SJ, et al. Hemiparesis is a clinical correlate of general adaptive dysfunction in children and adolescents with Sturge-Weber syndrome. J Child Neurol. 2009;24:701–8.PubMedCrossRef
53.
Zurück zum Zitat Chapieski L, Friedman D, Lachar D. Psychological functioning in children and adolescents with Sturge-Weber syndrome. J Child Neurol. 2000;15(10):660–5.PubMedCrossRef Chapieski L, Friedman D, Lachar D. Psychological functioning in children and adolescents with Sturge-Weber syndrome. J Child Neurol. 2000;15(10):660–5.PubMedCrossRef
54.
Zurück zum Zitat Sujansky E, Conradi S. Outcome of Sturge-Weber syndrome in 52 adults. Am J Med Genet. 1995;57(1):35–45.PubMedCrossRef Sujansky E, Conradi S. Outcome of Sturge-Weber syndrome in 52 adults. Am J Med Genet. 1995;57(1):35–45.PubMedCrossRef
55.
Zurück zum Zitat Lance EI, Lanier KE, Zabel TA, Comi AC. Stimulant use in patients with Sturge-Weber Syndrome: safety and efficacy. Abstract presented at Child Neurology Society; Nov. 2012. Lance EI, Lanier KE, Zabel TA, Comi AC. Stimulant use in patients with Sturge-Weber Syndrome: safety and efficacy. Abstract presented at Child Neurology Society; Nov. 2012.
56.
Zurück zum Zitat Suskauer SJ, Trovato MK, Zabel TA, et al. Physiatric findings in individuals with Sturge-Weber syndrome. Am J Phys Med Rehabil. 2010;89(4):323–30.PubMedCrossRef Suskauer SJ, Trovato MK, Zabel TA, et al. Physiatric findings in individuals with Sturge-Weber syndrome. Am J Phys Med Rehabil. 2010;89(4):323–30.PubMedCrossRef
Metadaten
Titel
Sturge-Weber Syndrome
verfasst von
Catherine D. Bachur, BA
Anne M. Comi, MD
Publikationsdatum
01.10.2013
Verlag
Springer US
Erschienen in
Current Treatment Options in Neurology / Ausgabe 5/2013
Print ISSN: 1092-8480
Elektronische ISSN: 1534-3138
DOI
https://doi.org/10.1007/s11940-013-0253-6

Weitere Artikel der Ausgabe 5/2013

Current Treatment Options in Neurology 5/2013 Zur Ausgabe

CEREBROVASCULAR DISORDERS (HP ADAMS JR, SECTION EDITOR)

Status of Endovascular Interventions to Treat Acute Ischemic Stroke

Leitlinien kompakt für die Neurologie

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Akuter Schwindel: Wann lohnt sich eine MRT?

28.04.2024 Schwindel Nachrichten

Akuter Schwindel stellt oft eine diagnostische Herausforderung dar. Wie nützlich dabei eine MRT ist, hat eine Studie aus Finnland untersucht. Immerhin einer von sechs Patienten wurde mit akutem ischämischem Schlaganfall diagnostiziert.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Frühe Alzheimertherapie lohnt sich

25.04.2024 AAN-Jahrestagung 2024 Nachrichten

Ist die Tau-Last noch gering, scheint der Vorteil von Lecanemab besonders groß zu sein. Und beginnen Erkrankte verzögert mit der Behandlung, erreichen sie nicht mehr die kognitive Leistung wie bei einem früheren Start. Darauf deuten neue Analysen der Phase-3-Studie Clarity AD.

Viel Bewegung in der Parkinsonforschung

25.04.2024 Parkinson-Krankheit Nachrichten

Neue arznei- und zellbasierte Ansätze, Frühdiagnose mit Bewegungssensoren, Rückenmarkstimulation gegen Gehblockaden – in der Parkinsonforschung tut sich einiges. Auf dem Deutschen Parkinsonkongress ging es auch viel um technische Innovationen.

Update Neurologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.